Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FC90P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $67,042
Award facts
- Contract value 100% obligated
- $67,041.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $67,041.77 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on September 4, 2025, with completion expected by September 5, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office location. Dupixent is a biologic medication used to treat conditions including eczema, asthma, and chronic rhinosinusitis, reflecting the Defense Logistics Agency's medical supply chain procurement needs to support military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The arrangement reflects the Defense Logistics Agency's strategic approach to pharmaceutical procurement through prime vendor contracts that provide flexible and comprehensive supply capabilities to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FC90P?
SPE2DB25FC90P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FC90P worth?
The government has obligated $67,042 on SPE2DB25FC90P.
Is contract SPE2DB25FC90P an order under another contract?
Yes. SPE2DB25FC90P is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB25FC90P competed?
The extent of competition for SPE2DB25FC90P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award